JERICHO SCIENCES
Dead / Abandoned — Abandoned — no statement of use filed (as of 27 Sept 2021)
What this means for you
This application is over — abandoned 27 Sept 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87783010
- Mark type
- Stylized text
- Filed
- 03 Feb 2018
- Published for opposition
- 26 Jun 2018
- Abandoned
- 27 Sept 2021
- Attorney of record
- Shane Cortesi
Goods and services
- Class 005 — Pharmaceuticals: Antibacterial pharmaceuticals; Antivirals; Biometallic compounds being a component in pharmaceutical preparations for infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Biometallic compounds for consumption and/or injection for use in medical imaging and for diagnostic purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic reagents for medicinal use; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents; Ocular pharmaceuticals; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Syringes sold filled with pharmaceuticals for treating infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Therapeutic pharmaceutical for the treatment of infectious disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products for the prevention and treatment of cancer
Owner
- Jericho Sciences, LLC, Research Triangle, NC, US
- Jericho Sciences, LLC, Nashville, TN, US
Prosecution history
- 27 Sept 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 27 Sept 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 20 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2021 — SOU EXTENSION 5 GRANTED
- 15 Feb 2021 — SOU EXTENSION 5 FILED
- 15 Feb 2021 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2020 — SOU EXTENSION 4 GRANTED
- 18 Aug 2020 — SOU EXTENSION 4 FILED
- 18 Aug 2020 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2020 — SOU EXTENSION 3 GRANTED
- 18 Feb 2020 — SOU EXTENSION 3 FILED
- 27 Feb 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Feb 2020 — SOU TEAS EXTENSION RECEIVED